CIK 0001894562 · <br>Emerging growth company
Prime Medicine, Inc.
Sign in to watch- Ticker
- PRME
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-465-0013
- Business address
- 60 FIRST ST., CAMBRIDGE, MA, 02141
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- FWP Offering Free Writing Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- S-8 Other Securities Offered to Employees in Benefit Plans
- CERT Other Certification
- 8-A12B Other Registration of Securities
- FWP Offering Free Writing Prospectus
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DRSLTR Other Correspondence Related to Draft Registration Statement
Page 2 of 3 · 49 filings